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ABSTRACT
The ‘randomised database study’ strategy was ﬁrst
proposed in 1997, with the aim of combining the
generalisability of observational database studies
based on electronic patient records (EPRs) with
the validity of randomised clinical trials (RCTs).
The key feature was to randomly assign treatments
and to use routine care data, as available in the
observational database, for patient identiﬁcation
and follow-up. To our knowledge, however, the idea
of the randomised database study has not been
implemented yet.
The conduct of a randomised study in an obser-
vational database requires adjustments to methods
of medical information processing in the general
practice.We developed a software system that facil-
itates the conduct of an RCT with observational
databases based on EPRs. It identiﬁes eligible sub-
jects and presents them one by one to the physician
once their EPR is accessed. The general practitioner
can then start an interactive recruitment process;
after completion, the computer randomises the
patients. Follow-up is documented by normal rou-
tine care in the EPR.
Although the randomised database study has
many methodological advantages, it has never been
tested. Our software system is meant as a tool to
implement and facilitate evaluation of the random-
ised database approach.
Keywords: electronic patient record (EPR),
observational study, pragmatic, randomised clinical
trial
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Introduction
The randomised controlled trial (RCT) is considered
the gold standard in clinical research. The main
objective of anRCT is to evaluate whether an interven-
tion is eﬃcacious.1 This evaluation is usually performed
by randomisation, blinding, intensive patient monitor-
ing, and strict management according to Good Clin-
ical Practice (GCP) guidelines and protocols. Although
these conditions facilitate the measurements of treat-
ment eﬀects, they limit generalisation of the results to
other populations and settings.
Observational studies usually have a greater gen-
eralisability because they cover treatment patterns in
normal care.2 However, the absence of randomisation
in the treatment allocation often hampers sound com-
parison between treatments. Hence, observational
studies are considered unsuitable for the evaluation
of eﬀectiveness of treatments.3,4
General practitioners (GPs) are faced with the
problem of applying evidence from studies that are
conducted in strictly controlled settings to patients
in normal care.5,6 Ideally, for them, evidence of
treatment eﬀectiveness should be obtained in routine
care, in pragmatic randomised trials with patients
normally seen by GPs.7 Although RCTs in general
practice may have better applicability to the primary
care setting, there are many diﬃculties in conducting
them.8–10 Frequently reported problems are lack of
time, recruitment of investigators and patients, ob-
taining informed consent, randomisation and data
collection. However, most of the randomised studies
in general practice use conventional methods for patient
selection, recruitment and data collection.
A new approach that could facilitate RCTs in general
practice is the randomised database study that was
proposed by Sarcristan and colleagues in 1997.11 This
approach is basedongoodexperiencewithobservational
databases based on electronic patient records (EPRs)
in the conduct of observational outcomes studies. An
observational database in this context contains data
on regular patient care, which is collected for other
purposes than research. Sarcristan argues that inclusion
of a randomisation module in the EPR would allow
assessment of drug eﬀectiveness in a large population.12
The EPRwould further function as a source for patient
selection, and data collection during a naturalistic
follow-up, as in observational studies. Although re-
searchers recognised the advantages of randomised
database studies, to our knowledge none have been
implemented.
The conduct of a randomised database study re-
quires adjustments or additions to routinemethods of
processing medical information with the EPR system.
The objective of this paper is to describe additions to
the method of information processing with an EPR
system that facilitate the conduct of a randomised
database study.
Method
The proposed adjustments in data processing methods
are meant to facilitate the conduct of a randomised
study within the normal care process; they are made
possible by installation of additional software in the
EPR system. The RCT procedures and the proposed
additions to the EPR system are described in Table 1.
Setting
The setting of this study is an ongoing longitudinal
general practice research database, the Integrated
Primary Care Information database (IPCI). This
Table 1 Integration of the EPR into randomised clinical trial procedures
Randomised trial
procedure
Integrated task of the EPR
Patient selection The physician’s patient database is used to identify and ﬂag all eligible subjects
Patient recruitment Additional software in the EPR may aid by reminding, and data pre-processing
Informed consent Documentation of consent and reason for refusal of patients
Randomisation Recruited patients are automatically randomised by a randomisation module in
the EPR
Data collection
during follow-up
Routine patient care data are used for outcome assessment
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database is described inmore detail elsewhere, and has
been used extensively for observational epidemiologic
and drug outcomes studies.13 In brief, the IPCI re-
search database contains ELIAS EPRs of over 500 000
patients from 150 physicians throughout The Nether-
lands. (ELIAS is a Dutch primary care EPR system.)
The database comprises patient demographic infor-
mation (date of birth, sex, anonymous patient identi-
ﬁcation, insurance, date of registration and transferring
out, date of death), medical notes, diagnoses (both as
codes and as free text), prescriptions and indications
for therapy, physical ﬁndings, referrals, hospitalis-
ations and laboratory values. The method we describe
allows for a randomised study in the setting of the IPCI
database.
Patient selection
The ﬁrst process in the conduct of an RCT is the
identiﬁcation and selection of potential patients (see
Table 1). The physicians or investigators usually do
not systematically search for eligible patients, and
recruitment may be organised by asking consecutively
presenting patients. Patients included are generally
not compared with non-included eligible patients
(since these are not identiﬁed), therefore little can be
said about the generalisability of the data.14,15
In our approach, the EPR database is used to select
potential patients. With tailored software, the re-
searchers may build queries to select eligible patients
in the individual EPR systems. This method standard-
ises the selection procedure across research sites. An
additional advantage is that all eligible subjects in the
complete source population are identiﬁed and marked.
Availability of demographic and medical information
on all eligible subjects in the database allows for
detailed comparison of included and non-included
patients and a better estimate of external validity.
Patient recruitment
The second process in a randomised study is patient
recruitment. GCP guidelines require a signed informed
consent if a patient is randomised to treatment, even if
these treatments are already licensed for marketing.
Physicians often fail to recruit a suﬃcient sample due
to waning enthusiasm and the time needed to com-
plete the recruitment process.16,17 Providing infor-
mation and asking for participation is probably one of
the major hurdles in recruitment, and little can be
done to reduce the recruitment time. Due to lack of
time and disruption of normal care, physicians per-
ceive it as diﬃcult to ask their patients to participate
and to address all their questions during a normal
consultation.18
We developed an interactive software module with
a reminder and data pre-processing function to facili-
tate the recruitment process. As soon as the EPR of a
selected patient is opened, the physician is informed
about the eligibility of the patient and given the option
to start the recruitment procedure. The software also
enables researchers to monitor inclusion and the
reasons for exclusion.
Randomisation
In conventional multi-centre clinical trials, random-
isation usually occurs at one co-ordinating centre.
However, while centralised randomisation is often
used, decentralised remote access, via web or tele-
phone, is increasingly employed.
With the EPR software, randomisation is conduc-
ted automatically in the EPR system after recruitment
is ﬁnalised. The incorporated randomisation scheme
should be unpredictable in order to avoid anticipation
of treatment assignment by the GP, especially if the
trial is not blinded.
Data collection and patient
assessment
Data collection in standard RCTs is often done by
means of paper-based case report forms and stand-
ardised questionnaires. Errors and incompleteness are
monitored and corrected as far as possible by a clinical
research organisation. Even though this method en-
sures complete and accurate data, it is labour-intensive.
Since all the important clinical ﬁndings and baseline
characteristics are usually documented in the EPR,
it can be used as the primary information source for
baseline information and clinical outcome assess-
ment.
Case study
We implemented a randomised database study to
compare gastrointestinal tolerability of diclofenac
and celecoxib in patients diagnosed with osteoarthritis.
Project-speciﬁc software was built and implemented
in the EPR systems of the participating GPs. The local
EPR databases were used to select patients older than
18 years of age who were diagnosed with osteoar-
thritis. Patient selectionwas based on historical data in
coded and free text format. Researchers reduced false
positive hits by manually validating selections based
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on free text information. The software was installed in
the EPR system of 42 GPs and it selected 7127 possible
candidates. These patients were the source population
from which the study population later emerged.
An electronic reminder was placed in the EPRs of
the selected patients to enable immediate recognition
by the GP when the patient visited. If a patient diag-
nosed with osteoarthritis required a non-steroidal
anti-inﬂammatory drug treatment during that regular
visit, the GP could start the interactive recruitment
procedure facilitated by the installed softwaremodule.
The GP could verify the inclusion and exclusion criteria
(for example, contraindication to the treatment under
study) and the software documented the inclusion or
reason for exclusion in the EPR system. As a result, we
could quantify the number of patients who refused to
participate, those excluded because of exclusion cri-
teria, and the number of patients ‘missed’ by the GPs.
Immediately after written informed consent was
obtained, the patient was allocated to diclofenac or to
celecoxib by the randomisation software. The data
recorded with the EPR during the naturalistic course
of the treatment were sent to the central observational
database (IPCI). This database was used to assess
outcomes, as done in other observational studies.
Discussion
In this paper, we proposed a method of using the EPR
in the conduct of an RCT and described software de-
signed for the practical implementation of a random-
ised database study. The major advantages of this
method are, ﬁrstly, the potential reduction in resources
needed to conduct a study, and secondly, the avail-
ability of detailed information about external validity,
since medical and demographic information of both
included and non-included patients is available.
Although the idea is attractive, the randomised
database study is not without limitations or prerequi-
sites. The successful implementation depends on the
possibilities of interfering with the existing EPR sys-
tem and the method of processing medical infor-
mation during normal clinical practice.
In order to minimise disruption of normal consul-
tation routines, we inserted an electronic reminder
system to alert the GPs about eligible patients, but
subsequent steps had to be initiated by the GP.
Although this gives some freedom to the GP, it might
also lead to non-inclusion and therefore selection bias.
Because we had demographic and medical information
on the entire source population, however, it is now
possible to estimate themagnitude of such selection bias.
By national regulation, both the GPs’ and the
patients’ identities are conﬁdential in observational
databases that are used for medical research.19 How-
ever, for the randomised database study, named in-
formed consent is required.20 The requirement to
keep the level of privacy in line with national regu-
lations increases the complexity of communication
between the researchers, the research database organ-
isation and the physicians. We used an extra identiﬁ-
cation number on top of the anonymous IPCI number
to avoid the possibility of the patient name being
directly linked to the existing database number, which
would otherwise lead to the possibility of unauthor-
ised access to non-anonymised medical information
in subsequent studies.
The randomised database study approach is a
clinical trial under the terms of the GCP guidelines.
As a result, the principles of the GCP need to be
followed; this could potentially reduce the possible
resource savings. For example, if a patient is found to
be eligible during a consultation, extra time is necess-
ary to explain the study and obtain informed consent.
However, the need for this extra time cannot readily be
anticipated and scheduled, which could create prob-
lems during busy consultation sessions.
With the randomised database study, it is diﬃcult
to adhere to the GCP requirements regarding docu-
mentation, since the EPR rather than a case report
form is the primary data collection tool.20 GCP requires
that source information cannot be altered. AnEPRcan
be changed retrospectively, which could go unnoticed
if time stamping does not occur accurately. Therefore,
the EPR may not be considered as a source document
and a time-stamped printed version of the medical
record in the database should be used instead.
Investigator recruitment is a major obstacle in the
conduct of RCTs in general practice. GPs recognise the
need to improve evidence-based medicine in primary
care, but their lack of participation in clinical trials is
also evident.21–23 GPs report the lack of support staﬀ
for research as being amajor barrier to participation in
RCTs. However, use of a clinical research nurse requires
a change in the study strategy. It would not be cost-
eﬃcient to recruit patients only when they present
themselves at normal visits. Preferably, they should be
called in actively. Although the proposed software
might facilitate the conduct of a randomised study
in general practice, it cannot remove all obstacles, and
participation will always increase the workload. Suf-
ﬁcient patient recruitment may therefore remain a
problem even with the proposed methods.
Conclusions
In summary, this paper describes our approach to
actually implementing a randomised database study.
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With adjustments and additions to the methods of
information processing with the EPR, the selection,
recruitment, randomisation and data collection pro-
cesses of an RCT can be integrated into the normal
care process. Our case study proved that it is possible.
However, now that it is possible to facilitate the
‘randomised database study’, it should be evaluated
on its validity and performance.
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